Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

607 Press Releases
DateTitleCompany
24 Aug 15 Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the ESC Congress 2015 Pfizer,
Published by
Pharmiweb.com
24 Aug 15 Pfizer Receives Clearance from U.S. Federal Trade Commission for Hospira Acquisition Pfizer,
Published by
Pharmiweb.com
24 Aug 15 Pfizer Announces Positive Topline Results Of Two Phase 3 Studies Of TRUMENBA® (Meningococcal Group B Vaccine) Pfizer,
Published by
Pharmiweb.com
24 Aug 15 Pfizer Announces European Medicines Agency Validates Marketing Authorization Application for IBRANCE® (palbociclib) in Combination with Endocrine Therapy for the Treatment of HR+/HER2- Metastatic Breast Cancer Pfizer,
Published by
Pharmiweb.com
24 Aug 15 Pfizer Receives Clearance from U.S. Federal Trade Commission for Hospira Acquisition Pfizer Inc.,
Published by
Business Wire
21 Aug 15 Pfizer Announces Positive Topline Results Of Two Phase 3 Studies Of TRUMENBA® (Meningococcal Group B Vaccine) Pfizer Inc.,
Published by
Business Wire
20 Aug 15 Pfizer Announces European Medicines Agency Validates Marketing Authorization Application for IBRANCE® (palbociclib) in Combination with Endocrine Therapy for the Treatment of HR+/HER2- Metastatic Breast Cancer Pfizer Inc.,
Published by
Business Wire
17 Aug 15 Pfizer Granted Approval From The Canadian Competition Bureau For Hospira Acquisition Pfizer,
Published by
Pharmiweb.com
14 Aug 15 Pfizer Granted Approval From The Canadian Competition Bureau For Hospira Acquisition Pfizer Inc.,
Published by
Business Wire
13 Aug 15 Pfizer Receives Approval from the Australian Competition and Consumer Commission for Pending Acquisition of Hospira Pfizer,
Published by
Pharmiweb.com
06 Aug 15 Pfizer Receives Approval From European Commission For Pending Acquisition Of Hospira Pfizer,
Published by
PharmiWeb.com
05 Aug 15 Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis Pfizer,
Published by
PharmiWeb.com
04 Aug 15 Pfizer Receives Approval From European Commission For Pending Acquisition Of Hospira Pfizer Inc.,
Published by
Business Wire
03 Aug 15 Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis Pfizer Inc.,
Published by
Business Wire
28 Jul 15 Pfizer Reports Second-Quarter 2015 Results Pfizer,
Published by
PharmiWeb.com
22 Jul 15 Pfizer Announces Expansion of Lease Agreement with Massachusetts Institute of Technology Subsidiary for Kendall Square Research Facility Pfizer,
Published by
PharmiWeb.com
22 Jul 15 Pfizer Announces Expansion of Lease Agreement with Massachusetts Institute of Technology Subsidiary for Kendall Square Research Facility Pfizer,
Published by
Business Wire
21 Jul 15 America's Most-Preferred Bone Health Brand Launches New Caltrate® Bone & Joint Health Supplement Pfizer Inc.,
Published by
Business Wire
08 Jul 15 Pfizer’s Centers For Therapeutic Innovation And Jeffrey Modell Foundation Announce Collaboration to Help Advance Immunological Research Pfizer,
Published by
PharmiWeb.com
08 Jul 15 Pfizer’s Centers For Therapeutic Innovation And Jeffrey Modell Foundation Announce Collaboration to Help Advance Immunological Research Pfizer Inc.,
Published by
Business Wire
07 Jul 15 Pfizer Begins Phase 2b Study Of Its Investigational Multi-antigen Staphylococcus aureus Vaccine In Adults Undergoing Elective Spinal Fusion Surgery Pfizer,
Published by
PharmiWeb.com
07 Jul 15 Pfizer Begins Phase 2b Study Of Its Investigational Multi-antigen Staphylococcus aureus Vaccine In Adults Undergoing Elective Spinal Fusion Surgery Pfizer Inc.,
Published by
Business Wire
03 Jul 15 Pfizer Announces FDA Acceptance for Review of New Drug Application for A Once-Daily Formulation of XELJANZ® (tofacitinib citrate) Modified Release Tablets Pfizer,
Published by
PharmiWeb.com
02 Jul 15 Pfizer Announces FDA Acceptance for Review of New Drug Application for A Once-Daily Formulation of XELJANZ® (tofacitinib citrate) Modified Release Tablets Pfizer Inc.,
Published by
Business Wire
25 Jun 15 Pfizer Declares 28-Cent Third-Quarter 2015 Dividend Pfizer,
Published by
PharmiWeb.com
25 Jun 15 Joseph J. Echevarria Elected To Pfizer’s Board Of Directors Pfizer,
Published by
PharmiWeb.com
25 Jun 15 Pfizer Declares 28-Cent Third-Quarter 2015 Dividend Pfizer Inc.,
Published by
Business Wire
25 Jun 15 Joseph J. Echevarria Elected To Pfizer’s Board Of Directors Pfizer Inc.,
Published by
Business Wire
24 Jun 15 CDC Advisory Committee on Immunization Practices Votes to Recommend Serogroup B Meningococcal Disease Vaccination including TRUMENBA® for Adolescents and Young Adults 16 through 23 Years of Age Pfizer,
Published by
PharmiWeb.com
24 Jun 15 CDC Advisory Committee on Immunization Practices Votes to Recommend Serogroup B Meningococcal Disease Vaccination including TRUMENBA® for Adolescents and Young Adults 16 through 23 Years of Age Pfizer Inc.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.